Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cell-based Assays Market, by Application
1.4.2 North America Cell-based Assays Market, by End User
1.4.3 North America Cell-based Assays Market, by Products & Services
1.4.4 North America Cell-based Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2021, Jun) Leading Players
Chapter 4. North America Cell-based Assays Market by Application
4.1 North America Drug Discovery Market by Country
4.2 North America Basic Research Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Cell-based Assays Market by End-use
5.1 North America Pharmaceutical & Biotechnology Companies Market by Country
5.2 North America Academic & Research Institutes Market by Country
5.3 North America Contract Research Organizations (CROs) Market by Country
Chapter 6. North America Cell-based Assays Market by Products & Services
6.1 North America Assay Kits Market by Country
6.2 North America Reagents Market by Country
6.3 North America Microplates Market by Country
6.4 North America Probes & Labels Market by Country
6.5 North America Instruments & Software Market by Country
6.6 North America Cell Lines Market by Country
Chapter 7. North America Cell-based Assays Market by Country
7.1 US Cell-based Assays Market
7.1.1 US Cell-based Assays Market by Application
7.1.2 US Cell-based Assays Market by End-use
7.1.3 US Cell-based Assays Market by Products & Services
7.2 Canada Cell-based Assays Market
7.2.1 Canada Cell-based Assays Market by Application
7.2.2 Canada Cell-based Assays Market by End-use
7.2.3 Canada Cell-based Assays Market by Products & Services
7.3 Mexico Cell-based Assays Market
7.3.1 Mexico Cell-based Assays Market by Application
7.3.2 Mexico Cell-based Assays Market by End-use
7.3.3 Mexico Cell-based Assays Market by Products & Services
7.4 Rest of North America Cell-based Assays Market
7.4.1 Rest of North America Cell-based Assays Market by Application
7.4.2 Rest of North America Cell-based Assays Market by End-use
7.4.3 Rest of North America Cell-based Assays Market by Products & Services
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Approvals and Trials:
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Geographical Expansions:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.5.4.2 Acquisition and Mergers:
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Merck Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Lonza Group AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Corning Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.10. Promega Corporation
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
Unique Offerings 